Johns Hopkins ABX Guide
Cefiderocol
INDICATIONS
FDA
FDA
- Patients ≥18 y/o for the treatment of the following infections caused by susceptible Gram-negative microorganisms:
- Complicated urinary tract infections (cUTI), including pyelonephritis
- Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- MDR GNR (e.g. Pseudomonas, Acinetobacter, CRO) infections when no other alternatives are available
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 9, 2020
Citation
Avdic, Edina. "Cefiderocol." Johns Hopkins ABX Guide, The Johns Hopkins University, 2020. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540740/all/Cefiderocol.
Avdic E. Cefiderocol. Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540740/all/Cefiderocol. Accessed November 5, 2024.
Avdic, E. (2020). Cefiderocol. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540740/all/Cefiderocol
Avdic E. Cefiderocol [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. [cited 2024 November 05]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540740/all/Cefiderocol.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefiderocol
ID - 540740
A1 - Avdic,Edina,Pharm.D.
Y1 - 2020/11/09/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540740/all/Cefiderocol
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
